Cargando…
Inhibition of Mitochondrial Complex I Impairs Release of α-Galactosidase by Jurkat Cells
Fabry disease (FD) is caused by mutations in the GLA gene that encodes lysosomal α-galactosidase-A (α-gal-A). A number of pathogenic mechanisms have been proposed and these include loss of mitochondrial respiratory chain activity. For FD, gene therapy is beginning to be applied as a treatment. In vi...
Autores principales: | Lambert, Jonathan R. A., Howe, Steven J., Rahim, Ahad A., Burke, Derek G., Heales, Simon J. R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770804/ https://www.ncbi.nlm.nih.gov/pubmed/31491876 http://dx.doi.org/10.3390/ijms20184349 |
Ejemplares similares
-
Release of β-galactosidase from poloxamine/α-cyclodextrin hydrogels
por: Estévez, César A, et al.
Publicado: (2014) -
New α-galactosidase-inhibiting aminohydroxycyclopentanes
por: Weber, Patrick, et al.
Publicado: (2021) -
Mutation patterns in human α-galactosidase A
por: Yan, Shaomin, et al.
Publicado: (2009) -
Thermostability of Probiotics and Their α-Galactosidases and the Potential for Bean Products
por: Liu, Xiaoli, et al.
Publicado: (2014) -
Optimizing human α-galactosidase for treatment of Fabry disease
por: Hallows, William C., et al.
Publicado: (2023)